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Young children experience frequent acute respiratory infections (ARIs). Of these, lower 
respiratory tract infections are associated with an increased risk of developing 
childhood asthma. The association between upper respiratory infections and 
subsequent childhood asthma is not yet equally well understood. 
In this study, 923 children were followed with symptom diaries for ARIs from birth 
until two years of age. During ARIs, nasal swabs for respiratory viruses were acquired. 
Primary outcome was a diagnosed asthma in electronic medical records or a 
prescription for an inhalation corticosteroid at 6.5 to 7.5 years of age. The association 
between ARIs and the risk of asthma was evaluated using binary logistic regression 
analysis. 
Electronic prescriptions and medical records were available for 910 (99%) children. A 
total of 8795 ARIs were recorded, with a mean number of 6.2 (95% confidence interval 
[CI] 6.0-6.4) per child per year. Asthma was documented at age 7 years in 75 (8%) 
children. Increased number of ARIs (≥9/year vs <5/year) during 0-2 years of age was 
associated with an increased risk of asthma at age 7 (adjusted odds ratio 7.20, 95% CI 
2.49‒20.88), as were more severe and prolonged ARIs. Children who developed 
asthma had more days with ARI symptoms per year before 2 years of age than other 
children (mean 65 vs 50, p=0.01). 
We found an association between early childhood ARIs and later childhood asthma. 
This association may stem from common pathophysiologic mechanisms, or ARIs in 
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In this population-based birth cohort study, increased number of acute respiratory infections 
in the first 24 months of life was associated with an increased risk for asthma at 7 years of 
age, suggesting shared pathophysiologic mechanisms. 
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To the Editor: 
Early lower respiratory tract infections are associated with an increased risk of developing 
childhood asthma.1 Young children experience frequent acute respiratory infections (ARIs) of 
which the vast majority are upper respiratory infections. While the research has mainly 
focused on lower respiratory infections, limited data exist on the association of all early ARIs 
and development of asthma. Results from previous studies are inconsistent1-6 and 
population-based data are sparse. We conducted a prospective, population-based birth 
cohort study to investigate the association between ARIs during the first 24 months of life 
and asthma at 7 years of age. 
Details of the methods and data analysis may be found in the Online repository. 
Briefly, in the STEPS study, 923 Finnish children were followed intensively for upper and 
lower ARIs from birth to 24 months of age.7 Data were collected with daily symptom diaries, 
study clinic visits, and from medical records. Nasal swab samples for respiratory viruses were 
taken at the onset of respiratory symptoms. Asthma diagnoses and medications were 
retrieved from medical records and electronic prescriptions at 7 years of age. Parents of 
participating children gave their written, informed consent. 
The primary outcome was physician-diagnosed asthma at 7 years of age, based on a 
diagnosis of asthma in the medical records or an electronic prescription of inhaled 
corticosteroids for asthma when the child was 6.5-7.5 years of age. Children who completed 
the follow-up on ARIs for ≥12 months were included in the analyses. Risk of asthma at 7 
years of age was analyzed by binary logistic regression analysis. 
Thirteen children withdrew from the study. Medical records and electronic 
prescriptions were reviewed for 910 (99%) children. Characteristics of the children are 
shown in Table E1. Altogether 781 (86%) children completed the follow-up on ARIs for ≥12 
months and the median completed follow-up time was 24.0 months (IQR, 20.2-24.0). 
A total of 8795 ARIs were recorded with a mean frequency of 6.2 (95% CI, 6.0-6.4) 
per  child per year. Altogether 273 doctor-diagnosed wheezing illnesses were documented in 
135 (17%) children and 46 (17%) led to hospitalization. Diagnosis of asthma was 
documented in 75 (8%) of 910 children at 7 years of age. A prescription for inhaled 
corticosteroids for asthma was documented in 70 (93%) of these children. 
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Children with asthma at 7 years of age had higher annual numbers of days with ARI 
symptoms, lower respiratory tract infections, physician visits, and antibiotics for ARIs at 0-23 
months of age as compared to children without asthma, and were more frequently 
hospitalized for ARI at 0-23 months of age (Table I). The median duration of ARIs at 0-23 
months of age was longer in children with asthma at 7 years of age than in those without 
later asthma (8.0 [IQR 5.0-12.0] vs. 7.0 [IQR, 4.0-12.0] days, P=0.04) and ARIs in children with 
later asthma were more severe, but the virus etiology did not differ (Table E2). 
Numbers of ARIs and days with ARI symptoms per year at 0-23 months of age were 
associated with an increased risk of asthma at 7 years of age (Table II). Compared to children 
with <5 ARIs/year at 0-23 months of age, children with ≥9 ARIs/year had a higher risk of 
asthma at 7 years of age (adjusted OR, 7.20; 95% CI, 2.49-20.88). Recurrent doctor-
diagnosed wheezing illnesses, hospitalization for wheezing, and wheezing caused by either 
RV or RSV at 0-23 months of age were associated with an increased risk of asthma. 
Association of background variables with asthma is shown in Table E3. 
In this population-based child cohort, we report that children with high frequency of 
early ARIs had an increased risk for asthma at 7 years of age. There are limited earlier data 
about the association of all ARIs –including also upper ARIs– at early age and later asthma in 
a population-based setting and earlier results are inconsistent.1-6 In line with our results, 
some earlier prospective studies have found that an increased number of all ARIs associate 
with the development of asthma.2, 3 Some previous studies have found no1, 4, 5 or even 
negative6 association between early upper ARIs and later asthma. However, many previous 
studies have assessed ARIs as a dichotomous variable, and frequently recurring infections, 
which in our study were associated with the development of asthma, have not been 
investigated.1, 4, 5 In some studies data have been collected by questionnaires which makes it 
difficult for parents to recall all past ARIs.1, 2, 5, 6 These data collection methods may have 
underestimated the effect of recurrent ARIs on asthma risk. In this study, use of symptom 
diaries allowed a more precise exposure-response-analysis, which showed a clear increase in 
the risk of asthma as both the number of ARI episodes and days with ARI symptoms 
increased. 
The mean duration of ARIs was longer and measures of severity were higher in 
children with asthma at 7 years of age compared with those without asthma. These findings 
may reflect poorer immunological responses in children who later develop asthma. Although 
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part of this morbidity is probably caused by wheezing illnesses, it is notable that the vast 
majority of ARIs presented without wheezing. Similar virus etiology of ARIs in children with 
and without later asthma is in line with an earlier report3 and suggests that there is no 
pathogen-specific immunologic weakness. 
Our findings suggest common mechanisms behind susceptibility to ARIs and asthma. 
Airway hyperreactivity in children who later develop asthma may contribute to prolonging 
symptoms during ARIs. Altered cytokine responses to respiratory viruses have been detected 
in children with asthma8 and could predispose to ARIs. Genetic factors or, as recent data 
suggest, airway microbiome9 may play a role in susceptibility to ARIs and asthma. Frequent 
early ARIs may also play a causative role in the development of asthma by adversely 
affecting the developing lungs.8 
There are limitations in this study. Outcome definition based partly on electronic 
prescriptions of inhaled corticosteroids enabled efficient data collection but it may have led 
to over- or underreporting of asthma. To avoid overreporting, we included only 
corticosteroid prescriptions with asthma as the indication of treatment. The follow-up time 
of early ARIs varied. However, we included in the analyses only children with follow-up of 
ARIs for ≥12 months.  
In conclusion, we found that increased number of ARIs in the first 24 months of life 
was associated with an increased risk of asthma at 7 years of age. Children who later 
developed asthma had more prolonged and severe ARIs in the first 24 months of life than 
other children. These results suggest that susceptibility to ARIs and asthma may share 
common pathophysiologic mechanisms, or recurrent ARIs in early childhood may predispose 
child to the development of asthma. 
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Table I. Numbers of acute respiratory infections at 0-23 months of age in children with and without asthma at 7 years of agea 
ARIs at 0-23 mo of age 
Children with 
asthma  
at 7 y of age, 
n = 63 
Children without asthma  
at 7 y of age, 
n = 718 
P 
No. of ARIs per year, mean (95% CI) 6.8 (6.1-7.7) 6.1 (5.9-6.3) 0.07 
No. of ARIs per year, n (%)   0.009 
 <5 14 (22.2) 261 (36.4)  
 5-8 31 (49.2) 347 (48.3)  
 ≥9 18 (28.6) 110 (15.3)  
No. of days with ARI symptoms per year, mean (95% CI) 64.8 (53.4-78.7) 50.2 (47.5-53.0) 0.01 
No. of days with wheezing per year, mean (95% CI) 5.2 (3.0-9.2) 1.6 (1.4-1.9) <0.001 
No. of RV infections per year, mean (95% CI) 2.0 (1.6-2.4) 2.0 (1.9-2.1) 0.94 
RSV infection, n (%) 21/60 (35)  201/676 (30) 0.39 
No. of physician visits for ARIs per year, mean (95% CI) 4.7 (3.8-5.8) 3.0 (2.8-3.2) <0.001 
Hospitalization for an ARI, n (%) 15 (23.8) 41 (5.7) <0.001 
No. of acute otitis media per year, mean (95% CI) 1.3 (1.0-1.7) 1.0 (0.9-1.0) 0.05 
No. of LRTIs per year, mean (95% CI) 0.3 (0.2-0.3) 0.0 (0.0-0.1) <0.001 
No. of wheezing illnesses, n (%)   <0.001 
 0 29 (46) 617 (86)  
 1 11 (18) 66 (9)  
 ≥2 23 (37) 35 (5)  
RV wheezing illness, n (%) 15/60 (25)  34/676 (5) <0.001 
RSV wheezing illness, n (%) 10/60 (17) 32/676 (5) <0.001 
Pneumonia, n (%) 10 (15.9) 26 (3.6) <0.001 
No. of antibiotic treatments for ARIs per year, mean (95% CI) 1.8 (1.4-2.4) 1.2 (1.1-1.3) 0.008 
Abbreviations: ARI, acute respiratory infection; RSV, respiratory syncytial virus; RV, rhinovirus. 
a In children with ≥12 month follow-up data on ARIs. Categorical data were compared by using the chi-square test or Fisher’s exact test. 
Numbers of ARIs and associated outcomes were compared by using negative binomial regression with the natural logarithm of follow-up time 
as an offset variable.
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Table II. Acute respiratory infections at 0-23 months of age and risk of asthma at 7 years of agea 
ARIs at 0-23 mo of age 
All children 
(n = 781), 
No. 
Children with asthma  
at 7 y of age 
(n = 63), 
No. (%) 
Adjusted OR (95% CI) 
No. of ARI episodes per year   1.17 (1.04-1.31) 
No. of ARI episodes per year    
 <5 275 14 (5.1) 1.00 
 5-8 378 31 (8.2) 2.80 (1.06-7.42) 
 ≥9 128 18 (14.1) 7.20 (2.49-20.88) 
No. of days with ARI symptoms per year, 
 per 10 days 
  1.12 (1.04-1.22) 
No. of RV infections per year    
 <2  455 38 (8.4) 1.00 
 ≥2 281 22 (7.8) 0.78 (0.40-1.52) 
RSV infection    
 0 514 39 (7.6) 1.00 




No. of LRTIs   2.03 (1.62-2.53) 
 No. of doctor-diagnosed wheezing illnesses    
  None 646 29 (4.5) 1.00 
  1 77 11 (14.3) 2.55 (0.95-6.87) 
  ≥2 58 23 (39.7) 16.91 (7.21-39.67) 
 Age at first wheezing episode, mo    
  0-11 76 17 (22.4) 1.00 
  12-23 59 17 (28.8) 1.33 (0.51-3.46) 
 Etiology of wheezing illnessesb    
  No wheezing 603 27 (4.5) 1.00 
  Wheezing, no detected RV or RSV 44 13 (29.5) 6.89 (2.45-19.32) 
  At least 1 RSV+ wheezing, no RV 32 5 (15.6) 4.90 (1.53-15.69) 
  At least 1 RV+ wheezing, no RSV 42 9 (21.4) 5.13 (1.76-14.94) 
  Both RSV+ and RV+ wheezing 15 6 (40.0) 13.93 (3.88-50.08) 
 Severity of wheezing illnesses    
  No wheezing 646 29 (4.5) 1.00 
  Wheezing illness without hospitalization 104 21 (20.2) 5.29 (2.46-11.38) 
  Hospitalized for a wheezing illness 31 13 (41.9) 14.93 (4.99-44.63) 
Hospitalization for an ARI    
 No 725 48 (6.6%) 1.00 
 Yes 56 15 (26.8%) 5.46 (2.27-13.14) 
No. of antibiotics for ARIs   1.20 (1.09-1.34) 
Abbreviations: ARI, acute respiratory infection; CI, confidence interval; LRTI, lower respiratory tract infection; OR, odds ratio; RSV, respiratory 
syncytial virus; RV, rhinovirus. 
a Risk of asthma was calculated by using multivariable binomial logistic regression analysis in children with ≥12 month follow-up data on ARIs. 
Sex, birth by cesarean section, child’s atopy at 13 month of age, parental asthma, and parental smoking were used as covariates. Results of 
unadjusted analyses are shown in Table E4. Association between ARIs at 0-11 months of age and risk of asthma are shown in Table E5. 
b Virus diagnostics was performed during 164 (60.1%) episodes of the total of 273 doctor-diagnosed wheezing illness. RV was detected in 77 
(47.0%) episodes of doctor-diagnosed wheezing illness, RSV in 47 (28.7%), and other virus in 9 (5.5%) episodes. 
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In the STEPS observational prospective birth cohort study, 1827 children born in 2008-2010 
in the Hospital District of Southwest Finland are followed from pregnancy or birth to early 
adulthood.1 An intensive follow-up of acute respiratory infections (ARIs) from birth to 24 
months of age of the child was offered to these families, and 923 children were enrolled.2 
The children were followed for ARIs through daily symptom diaries and the families were 
encouraged to visit the study clinic if they felt that an evaluation by a physician was needed. 
At the onset of respiratory symptoms, nasal swab samples were taken at the study clinic by a 
study physician, or at home by the parents and sent to the study clinic as previously 
described.2, 3 Background data was collected by structured questionnaires. Data on 
emergency room visits, hospitalizations, and outpatient visits at the hospitals for ARIs at 0-
23 months of age and asthma diagnoses until 7.5 years of age were retrieved from medical 
records of the Hospital District of Southwest Finland. Asthma medications until 7.5 years of 
age were retrieved from electronic prescriptions. 3, The electronic prescription was 
introduced in Finland in 2010, and all public health care providers had taken it in use latest in 
2013 and private health care providers by 2015. All pharmacies have been able to deliver 
electronic prescriptions since 2011. Electronic prescription became the main form of 
prescription in the beginning of 2017, and paper or phone prescriptions have been allowed 
only in exceptional situations. 
The Ministry of Social Affairs and Health and the Ethics Committee of the Hospital 
District of Southwest Finland approved the STEPS Study. Parents of participating children 
gave their written, informed consent. 
Respiratory virus detection 
The nasal swab samples were stored at -80°C before analysis. Swabs were suspended in 
phosphate buffered saline and nucleic acids were extracted by NucliSense easyMag 
(BioMerieux, Boxtel, Netherlands) or MagnaPure 96 (Roche, Penzberg, Germany) automated 
extractor. Extracted RNA was reverse transcribed and the cDNA was amplified using real-
time, quantitative PCR for RV, human enteroviruses and RSV as described earlier.4, 5 All 
specimens collected during influenza seasons were analyzed by reverse transcription PCR for 
influenza A and B viruses.6 For samples collected in January 2009 or later, laboratory 
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developed antigen detection tests were performed for influenza A and B viruses, 
parainfluenza type 1, 2, and 3 viruses, RSV, adenovirus, and human metapneumovirus (89% 
of samples).  
Outcome definition 
The primary outcome was physician-diagnosed asthma at 7 years of age, based on a 
diagnosis of asthma in the medical records, or a prescription of inhaled corticosteroids for 
asthma, when the child was 6.5-7.5 years of age. All asthma diagnoses and corticosteroid 
prescriptions were made by physicians. An acute respiratory infection (ARI) was defined as 
presence of rhinitis or cough, with or without fever or wheezing, documented in the 
symptom diary by the parents, or as an ARI diagnosed by a physician. The duration of 97.2% 
of ARIs was ≤ 30 days. To account for overlapping infections, the length of an ARI was limited 
to 30 days and longer ARIs (2.8%) were calculated as separate episodes with a maximum 
duration of 30 days. Wheezing illnesses (e.g., bronchiolitis, recurrent wheezing, or acute 
exacerbation of asthma) were diagnosed by a physician based on expiratory wheezing and 
other signs and symptoms. If there were repeated diagnoses of acute otitis media, wheezing 
illness, pneumonia, or laryngitis during continuous respiratory symptoms, diagnoses within 
14 days were calculated as one episode. Recurrent wheezing was defined as ≥ 2 doctor-
diagnosed wheezing illnesses at 0-23 months of age. Children who completed the follow-up 
on respiratory infections until at least 12 months of age were included in the analyses on the 
association between ARIs at 0-23 months of age and asthma at 7 years of age. 
Statistical analysis 
Categorical data were compared by using the chi-square test or Fisher’s exact test. 
Continuous data were described by using means and 95% confidence intervals (CI) or 
medians and interquartile ranges (IQR) as appropriate. Skewed data were compared by 
using Mann Whitney U test. Generalized linear models were used for describing and 
analyzing numbers of ARIs and associated outcomes. Outcome counts were analyzed by 
using negative binomial distribution and log link with natural logarithm of follow-up time as 
an offset variable. Numbers of ARIs and associated outcomes were compared by using 
negative binomial regression. Risk of asthma at 7 years of age was first analyzed by 
unadjusted binary logistic regression analysis. Adjusted binary logistic regression analyses 
were performed with background variables based on clinical plausibility and with P values < 
0.10 in the univariate analyses included in the final model (sex, birth by cesarean section, 
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child’s atopy at 13 months of age, parental asthma, and parental smoking at child’s age of 24 
months). Unadjusted and adjusted odds ratios (OR) with 95% CIs were determined. P values 
< 0.05 were considered statistically significant. 
The data were analyzed with the use of SPSS software, version 24.0 (IBM SPSS 
Statistics for Macintosh, Armonk, NY, USA: IBM Corp.), and SAS software for Windows, 
version 9.4 (SAS Institute Inc., Cary, NC, USA). 
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Table E1. Characteristics of the study children 
Characteristic 
All children, n (%) 
(N = 910) 
Female  430 (47.3) 
Premature (gestational age <37 wk) 37 (4.1) 
Birth by cesarean section 121 (13.3) 
Birth weight, kg  
 <2.5 25 (2.7) 
 2.5-4.5 866 (95.2) 
 >4.5 19 (2.1) 
Older siblings 373 (41.0) 
Maternal asthma 71/909 (7.8) 
Paternal asthma 57/853 (6.7) 
Parental asthma 120/909 (13.2) 
Maternal atopic eczema, allergy, or allergic rhinitis 320/879 (36.4) 
Paternal atopic eczema, allergy, or allergic rhinitis 201/853 (23.6) 
Parental atopic eczema, allergy, or allergic rhinitis 411/884 (46.5) 
Maternal smoking during pregnancy after 1st trimester 47/906 (5.2) 
Parental smoking at child’s age of 24 mo 102/628 (16.2) 
Maternal educational level at least professional 569/882 (64.5) 
Indoor pets at 3 or 24 mo of age 223/567 (39.3) 
Breast-fed for at least 6 mo 427/708 (60.3) 
At outside-home day-care, age  
     13 mo 184/775 (23.7) 
     18 mo 279/676 (41.3) 
     24 mo  366/674 (54.3) 
Atopic eczema at 13 mo of age 128/748 (17.1) 
Asthma at 7 y of age 75 (8.2) 
ARIs at 0-23 mo of agea  
 Mean number of ARIs per child per y (95% CI) 6.2 (6.0-6.4) 
 Mean number of days with ARI symptoms per child per y (95% CI) 51.3 (48.6-54.1) 
 Mean number of LRTIs per child per y (95% CI) 0.1 (0.1-0.1) 
 Wheezing illness 135/781 (17.3) 
 Recurrent wheezing illness (≥2) 58/781 (7.4) 
 No. of wheezing illnesses  
  0 646/781 (82.7) 
  1 77/781 (9.9) 
  2-3 36/781 (4.6) 
  ≥4 22/781 (2.8) 
 RV wheezing illness 49/736 (6.7) 
  Recurrent RV wheeze (≥2) 15/736 (2.0) 
 RSV wheezing illness 42/736 (5.7) 
 Age at first wheezing episode, mo  
  0-11 76/781 (9.7) 
  12-23 59/781 (7.6) 
Abbreviations: ARI, acute respiratory infection; CI, confidence interval; LRTI, lower respiratory tract 
infection; RSV, respiratory syncytial virus; RV, rhinovirus. 
a In children with ≥ 12 month follow-up data on ARIs (n=781).
 16 
Table E2. Characteristics of acute respiratory infections at 0-23 months of age in children with and without asthma at 7 years of agea 
Variable 
ARIs in children with 
asthma at 7 y of age, 
n = 800 
ARIs in children without asthma  
at 7 y of age, 
n = 7995 
P 
Median duration of an ARI, days (IQR) 8.0 (5.0-12.0) 7.0 (4.0-12.0) 0.04 
Symptoms during an ARI, No. (%)    
 Fever 253/705 (35.9) 2268/6979 (32.5) 0.07 
 Cough 469/705 (66.5) 3935/6979 (56.4) <0.001 
 Wheezing 158/705 (22.4) 580/6979 (8.3) <0.001 
 Rhinorrhea 642/705 (91.1) 6448/6979 (92.4) 0.21 
Child absent from day care during an ARI, No. (%)b 60/116 (51.7) 647/1783 (36.3) 0.001 
Parent absent from work during child’s ARI, No. (%)b 49/116 (42.2) 529/1783 (29.7) 0.004 
Physician visit during an ARI, No. (%) 387/800 (48.4) 3178/6979  (39.7) <0.001 
Hospitalization during an ARI, No. (%) 26/800 (3.3) 52/6979  (0.7) <0.001 
Diagnoses during an ARI, No. (%)    
 Acute otitis media 157/800 (19.6) 1249/6979  (15.6) 0.003 
 Wheezing illness 97/800 (12.1) 174/6979  (2.2) <0.001 
 Laryngitis 19/800 (2.4) 125/6979  (1.6) 0.09 
 Pneumonia 10/800 (1.3) 26/6979  (0.3) 0.001 
Antibiotic treatment during an ARI, No. (%) 200/800 (25.0) 1530/6979  (19.1) <0.001 
Virus detections during an ARI, No. (%)    
 Virus positive 269/384 (70.1) 2945/4151 (70.9) 0.71 
 RV 219/384 (57.0) 2452/4151 (59.1) 0.47 
 RSV 23/384 (6.0) 228/4151 (5.5)  
 Other virus 24/384 (6.3) 199/4151 (4.8)  
 Co-detection 3/384 (0.8) 66/4151 (1.6)  
Abbreviations: ARI, acute respiratory infection; IQR, interquartile range; RSV, respiratory syncytial virus; RV, rhinovirus. 
a In children with ≥12 month follow-up data on ARIs. Categorical data were compared by using the chi-square test or Fisher’s exact test. Median 
durations of ARIs were compared by using Mann Whitney U test. 
b Calculated among children at outside home day care at the time of ARI. 
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Table E3. Baseline risk factors for asthma at 7 years of age 
Characteristic 
All children 




at 7 y of age, 
No. (%) 
Univariate, 
OR (95% CI)a 
Multivariate, 
OR (95% CI)b 
Sex     
 Female 430  27 (6.3) 1.0 1.0 
 Male 480 48 (10.0) 1.66 (1.02-2.71) 2.28 (1.17-4.41) 
Birth by cesarean section     
 No 789 60 (7.6) 1.0 1.00 
 Yes 121 15 (12.4) 1.72 (0.94-3.14) 1.10 (0.47-2.59) 
Older siblings     
 No 537 46 (8.6) 1.0  
 Yes 373 29 (7.8) 0.90 (0.55-1.46)  
Child’s atopy at 13 mo of age     
 No 620 37 (6.0) 1.0 1.0 
 Yes 128 23 (18.0) 3.45 (1.97-6.05) 3.24 (1.66-6.33) 
Indoor pets     
 No 344 31(9.0) 1.0  
 Yes 223 16 (7.2) 0.78 (0.42-1.46)  
Maternal asthma     
 No 838 56 (6.7) 1.0  
 Yes 71 19 (26.8) 5.10 (2.83-9.22)  
Paternal asthma     
 No 796 60 (7.5) 1.0  
 Yes 57 13 (22.8) 3.62 (1.85-7.10)  
Parental asthma     
 No 789 47 (6.0) 1.0 1.0 
 Yes 120 28 (23.3) 4.81 (2.87-8.05) 6.49 (3.31-12.76) 
Maternal smoking during pregnancy     
 No 859 70 (8.1) 1.0  
 Yes 47 5 (10.6) 1.34 (0.51-3.50)  
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Parental smoking at child’s age of 24 mo     
 No 526 39 (7.4) 1.0 1.0 
 Yes 102  14 (13.7) 1.99 (1.04-3.81) 2.06 (0.99-4.29) 
Abbreviations: CI, confidence interval; OR, odds ratio. 
a Risk of asthma was calculated by using binomial logistic regression analysis. 
b Sex, birth by cesarean section, child’s atopy at 13 mo of age, parental asthma, and parental smoking as covariates.  
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Table E4. Full results of analysis of association between acute respiratory infections at 0-23 months of age and risk of asthma at 7 years of agea 
 
ARIs at 0-23 mo of age 
All children 
(n = 781), 
No. 
Children with asthma  
at 7 y of age 
(n = 63), 
No. (%) 
Univariate, 
OR (95% CI) 
Multivariate, 
OR (95% CI) 
No. of ARI episodes per year   1.09 (0.99-1.19) 1.17 (1.04-1.31) 
No. of ARI episodes per year     
 <5 275 14 (5.1) 1.0 1.0 
 5-8 378 31 (8.2) 1.67 (0.87-3.19) 2.80 (1.06-7.42) 
 ≥9 128 18 (14.1) 3.05 (1.47-6.35) 7.20 (2.49-20.88) 
No. of days with ARI symptoms per year, 
 per 10 days 
  1.11 (1.03-1.18) 1.12 (1.04-1.22) 
No. of RV infections per year     
 <2  455 38 (8.4) 1.00 1.00 
 ≥2 281 22 (7.8) 0.93 (0.54-1.61) 0.78 (0.40-1.52) 
RSV infection     
 0 514 39 (7.6) 1.00 1.00 
 ≥1 222 21 (9.5) 1.27 (0.73-2.22) 1.32 (0.68-2.58) 
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No. of LRTIs   1.90 (1.60-2.25) 2.03 (1.62-2.53) 
 Doctor-diagnosed wheezing illnesses     
  None 646 29 (4.5) 1.00 1.00 
  1 77 11 (14.3) 3.55 (1.69-7.43) 2.55 (0.95-6.87) 
  ≥2 58 23 (39.7) 13.98 (7.34-26.64) 16.91 (7.21-39.67) 
 Age at first wheezing episode, mo     
  0-11 76 17 (22.4) 1.00 1.00 
  12-23 59 17 (28.8) 1.41 (0.64-3.07) 1.33 (0.51-3.46) 
 Etiology of wheezing illnessesb     
  No wheezing 603 27 (4.5) 1.00 1.00 
  Wheezing, no detected RV or RSV 44 13 (29.5) 8.95 (4.21-19.01) 6.89 (2.45-19.32) 
  At least 1 RSV+ wheezing, no RV 32 5 (15.6) 3.95 (1.41-11.06) 4.90 (1.53-15.69) 
  At least 1 RV+ wheezing, no RSV 42 9 (21.4) 5.82 (2.53-13.37) 5.13 (1.76-14.94) 
  Both RSV+ and RV+ wheezing 15 6 (40.0) 14.22 (4.72-42.84) 13.93 (3.88-50.08) 
 Severity of wheezing illnesses     
  No wheezing 646 29 (4.5) 1.00 1.00 
  Wheezing illness without  
   hospitalization 
104 21 (20.2) 5.38 (2.94-9.87) 5.29 (2.46-11.38) 
  Hospitalized for a wheezing illness 31 13 (41.9) 15.37 (6.87-34.36) 14.93 (4.99-44.63) 
Hospitalization for an ARI     
 No 725 48 (6.6%) 1.00 1.00 
 Yes 56 15 (26.8%) 5.16 (2.67-9.98) 5.46 (2.27-13.14) 
No. of antibiotics for ARIs   1.14 (1.06-1.24) 1.20 (1.09-1.34) 
Abbreviations: ARI, acute respiratory infection; CI, confidence interval; LRTI, lower respiratory tract infection; OR, odds ratio; RSV, respiratory 
syncytial virus; RV, rhinovirus. 
a Risk of asthma was calculated by using unadjusted and multivariable binomial logistic regression analysis in children with ≥12 month follow-up 
data on ARIs. In multivariable analyses, sex, birth by cesarean section, child’s atopy at 13 month of age, parental asthma, and parental smoking 
were used as covariates. 
b Virus diagnostics was performed during 164 (60.1%) episodes of the total of 273 doctor-diagnosed wheezing illness. RV was detected in 77 
(47.0%) episodes of doctor-diagnosed wheezing illness, RSV in 47 (28.7%), and other virus in 9 (5.5%) episodes.  
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Table E5. Acute respiratory infections at 0-11 months of age and risk of asthma at 7 years of agea 
 
ARIs at 0-11 mo of age 
All children 




at 7 y of age 
(n = 63), 
No. (%) 
Univariate, 
OR (95% CI) 
Multivariate, 
OR (95% CI) 
No. of ARI episodes   1.07 (0.99-1.16) 1.10 (1.00-1.22) 
No. of days with ARI symptoms, per 10 days   1.08 (1.01-1.16) 1.10 (1.02-1.19) 
No. of RV infections     
 <2  336 24 (7.1) 1.00 1.00 
 ≥2 400 36 (9.0) 1.29 (0.75-2.20) 1.29 (0.65-2.53) 
RSV infection     
 0 588 46 (7.8) 1.00 1.00 
 ≥1 148 14 (9.5) 1.23 (0.66-2.31) 1.22 (0.58-2.58) 
No. of LRTIs   2.12 (1.56-2.87) 2.12 (1.46-3.08) 
No. of doctor-diagnosed wheezing  
illnesses 
    
 None 705 46 (6.5) 1.00 1.00 
 1 51 10 (19.6) 3.49 (1.65-7.42) 3.33 (1.33-8.38) 
 ≥2 25 7 (28.0) 5.57 (2.21-14.02) 4.70 (1.37-16.15) 
Hospitalization for an ARI     
 No 745 54 (7.2) 1.00 1.00 
 Yes 36 9 (25.0) 4.27 (1.91-9.53) 6.72 (2.36-19.16) 
No. of antibiotics for ARIs   1.21 (1.03-1.41) 1.25 (1.04-1.50) 
Abbreviations: ARI, acute respiratory infection; CI, confidence interval; LRTI, lower respiratory tract infection; OR, odds ratio; RSV, respiratory 
syncytial virus; RV, rhinovirus. 
a Risk of asthma was calculated by using multivariable binomial logistic regression analysis in children with ≥12 month follow-up data on ARIs. 
Sex, birth by cesarean section, child’s atopy at 13 month of age, parental asthma, and parental smoking were used as covariates. 
 
 
